diroximel fumarate
Drug Details
- Generic Name
- diroximel fumarate
- Brand Names
- Vumerity
- Application Number
- NDA211855
- Sponsor
- Biogen Inc.
- NDC Codes
- 2
- Dosage Forms
- CAPSULE, CAPSULE, DELAYED RELEASE
- Routes
- ORAL
- Active Ingredients
- DIROXIMEL FUMARATE
Indications and Usage
1 INDICATIONS AND USAGE VUMERITY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. VUMERITY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )